accountChina Heparin Industry Report, 2010-2011,Research In China,Sep./2011,Price USD1700
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
CHINA BIOTECHNOLOGY
China appears destined to emerge as a global power in biotechnology. The government is investing heavily in biotech research institutes, foreign pharmaceutical companies are building major R&D labs, and a big contract research industry is growing in Shanghai and Beijing. We explore China’s progress and its implications.
China Biotechnology is part of Business Exchange, suggested by
Pete Engardio.
This topic contains
166 news
and
114 blog
items.
Read updated news, blogs, and resources about China Biotechnology. Find user-submitted articles and reactions on China Biotechnology from
like-minded professionals.
Blogs
Please add new articles to this topic
A Nature Network Bioentrepreneur Forum Blog.
By Vivian Ni Late last month, US-based SciClone Pharmaceuticals Inc. (NASDAQ: SCLN) announced it has completed an...
Aoxing Pharmaceutical (AMEX: AXN) and Johnson ... goal is to produce APIs for the China market.
Medical research equipment and services company plans to buy WuXi PharmaTech, a Chinese pharmaceutical outsourcing...
Charles River Laboratories said Monday that it had agreed to acquire WuXi Pharma Tech, a Chinese pharmaceutical...
Sanofi-Aventis (NYSE: SNY) has established a regional R&D center in Shanghai (see story) to develop and manage...
Ltd. (Artepharm China), a mid-sized pharmaceutical and...
Ltd. (Artepharm China), a mid-sized pharmaceutical and biotech company based in Guangzhou, China, who have successfu...
China), a mid-sized pharmaceutical and biotech company based in Guangzhou, China, who have successfully developed and...
US Food and Drug Administration ... in China has appeared. A new report (pdf) by the U.S. China ... one destination for...
...of a series B financing from China sources (see story). Zhejiang Hisun Pharmaceutical (SHA...
Hebei, Shandong, Liaoning and Bohai Sea region biotechnology is ... enterprises in China. ... of the most important...
...better access to Chinese patients, combining Tigermed’s knowledge of China drug...
...placed to exploit this opportunity are the Indian and Chinese pharmaceutical industries and...
...from its $100 million China VC fund, and, not surprisingly, expects to increase its China revenues this year.
...from its $100 million China VC fund, and, not surprisingly, expects to increase its China revenues this year.
...from China life science last week, there were four stories that involved relationships between Western life science...
...growth in the worldwide market in 2013. China is the ... Shanghai Zhangjiang Biotech & Pharmaceutical Base...
ChinaBio Today submits: It was a good week for fundings in China life science, with five companies announcing new...
It was a good week for fundings in China life science, with five companies announcing new capital.
FTSE/Xinhua China 25 Index. This index consists of 25 mega-cap Chinese...
...thinks China will be responsible for 21% of all growth in the worldwide pharmaceutical market in the next four years.
China's Ministry of Finance (MoF) announced Friday that the central...
Top Sources: China Biotechnology
- Moreover Technologies - Pharma industry news - 30 of 8657 returned
- pfblogs.org: The Ad-Free Personal Finance Blogs Aggregator
- SeekingAlpha.com: Home Page
- SeekingAlpha.com
- pfblogs.org: The Ad-Free Personal Finance Blogs Aggregator (investing blogs)
- Finance Roundtable
- China News latest RSS headlines - Asia Bulletin.com
- China Stocks News and Analysis from Seeking Alpha
- China News latest RSS headlines - China National News.com
- pharmalot.com
